Page last updated: 2024-11-02

picotamide and Thrombocythemia, Essential

picotamide has been researched along with Thrombocythemia, Essential in 1 studies

picotamide: has anticoagulant & fibrinolytic properties; structure

Thrombocythemia, Essential: A clinical syndrome characterized by repeated spontaneous hemorrhages and a remarkable increase in the number of circulating platelets.

Research Excerpts

ExcerptRelevanceReference
"Bleeding and thrombosis are major causes of morbidity and mortality in patients with chronic myeloproliferative disorders."1.29Thrombotic and hemorrhagic complications in chronic myeloproliferative disorders. ( Carpi, A; Ferretti, A; Nicolini, A; Sagripanti, A, 1996)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sagripanti, A1
Ferretti, A1
Nicolini, A1
Carpi, A1

Other Studies

1 other study available for picotamide and Thrombocythemia, Essential

ArticleYear
Thrombotic and hemorrhagic complications in chronic myeloproliferative disorders.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 1996, Volume: 50, Issue:8

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Chronic Disease; Female; Follow-Up Studies; Hemorrhage;

1996